Connect with us


UK Becomes First Country To Approve COVID Booster Vaccine Targeting Original And Omicron Strains

The Medicines and Healthcare products Regulatory Agency (MHRA) has given the green light to the Moderna vaccine as a “sharpened tool” against the novel coronavirus after it was found to meet its standards of safety, quality and effectiveness

UK Becomes First Country To Approve COVID Booster Vaccine Targeting Original And Omicron Strains
The UK has approved a “bivalent” COVID vaccine that targets both the original strain of COVID-19 and the newer Omicron variant

London: The UK has become the first country to approve a so-called “bivalent” COVID vaccine that targets both the original strain of COVID-19 and the newer Omicron variant, British health authorities announced on Monday (August 15). The Medicines and Healthcare products Regulatory Agency (MHRA) said it had given the green light to the Moderna vaccine as a “sharpened tool” against the novel coronavirus after it was found to meet its standards of safety, quality and effectiveness.

Also Read: COVID-19 Vaccine: Corbevax Approved As Precaution Dose For Adults Vaccinated With Covaxin, Covishield

In each dose of the booster vaccine, ‘Spikevax bivalent Original/Omicron’, half of the vaccine (25 micrograms) targets the original virus strain from 2020 and the other half (25 micrograms) targets Omicron, the regulator said.

I am pleased to announce the approval of the Moderna bivalent booster vaccine, which was found in the clinical trial to provide a strong immune response against the Omicron BA.1 variant as well as the original 2020 strain, said MHRA Chief Executive Dr June Raine.

“The first generation of COVID-19 vaccines being used in the UK continue to provide important protection against the disease and save lives. What this bivalent vaccine gives us is a sharpened tool in our armoury to help protect us against this disease as the virus continues to evolve,” she said.

The MHRA said its decision to grant approval for this booster vaccine in the UK was endorsed by the government’s independent expert scientific advisory body, the Commission on Human Medicines, after carefully reviewing the evidence. The regulator said its decision is based on data from a clinical trial, which showed that a booster with the bivalent Moderna vaccine triggers a strong immune response against both Omicron (BA.1) and the original 2020 strain. In an exploratory analysis, the bivalent vaccine was also found to generate a good immune response against the Omicron sub-variants BA.4 and BA.5.

Also Read: COVID-19 Vaccine: Gap Between Second COVID Jab And Booster Dose Reduced From 9 To 6 Months

The virus, SARS-CoV-2, is continually evolving in order to evade the immunity provided by vaccines. This novel bivalent vaccine represents the next step in the development of vaccines to combat the virus, with its ability to lead to a broader immune response than the original vaccine, said Professor Sir Munir Pirmohamed, Chair of the Commission on Human Medicines.

The authorities said that safety monitoring showed that the side effects observed were the same as those seen for the original Moderna booster dose and were typically mild and self-resolving, and no serious safety concerns were identified.

The UK’s independent Joint Committee on Vaccination and Immunisation (JCVI) will now advise on how this new vaccine should be rolled out as part of the country’s booster vaccine deployment programme.

The vaccine has also been submitted for approval with the authorities in Australia, Canada and the European Union (EU). It is expected that the EU medicines regulator will approve the dose by next month.

Moderna CEO Stephane Bancel described the new vaccine as a “next generation COVID-19 vaccine”, which will play an important role in protecting people over the winter.

This represents the first authorisation of an Omicron-containing bivalent vaccine, further highlighting the dedication and leadership of the UK public health authorities in helping to end the COVID-19 pandemic. This bivalent vaccine has an important role to play in protecting people in the UK from COVID-19 as we enter the winter months, said Bancel.

According to official statistics, 126,504,756 vaccine doses have been administered in the UK including first and second doses as well as third and fourth booster doses rolled out on an age group basis.

Also Read: PM Modi Writes To Vaccinators, Lauds Their Efforts As India Crosses 200 Crore Vaccine Doses Landmark

(This story has not been edited by NDTV staff and is published from a syndicated feed.)

NDTV – Dettol have been working towards a clean and healthy India since 2014 via the Banega Swachh India initiative, which is helmed by Campaign Ambassador Amitabh Bachchan. The campaign aims to highlight the inter-dependency of humans and the environment, and of humans on one another with the focus on One Health, One Planet, One Future – Leaving No One Behind. It stresses on the need to take care of, and consider, everyone’s health in India – especially vulnerable communities – the LGBTQ populationindigenous people, India’s different tribes, ethnic and linguistic minorities, people with disabilities, migrants, geographically remote populations, gender and sexual minorities. In wake of the current COVID-19 pandemic, the need for WASH (WaterSanitation and Hygiene) is reaffirmed as handwashing is one of the ways to prevent Coronavirus infection and other diseases. The campaign will continue to raise awareness on the same along with focussing on the importance of nutrition and healthcare for women and children, fight malnutrition, mental wellbeing, self care, science and health, adolescent health & gender awareness. Along with the health of people, the campaign has realised the need to also take care of the health of the eco-system. Our environment is fragile due to human activity, which is not only over-exploiting available resources, but also generating immense pollution as a result of using and extracting those resources. The imbalance has also led to immense biodiversity loss that has caused one of the biggest threats to human survival – climate change. It has now been described as a “code red for humanity.” The campaign will continue to cover issues like air pollutionwaste managementplastic banmanual scavenging and sanitation workers and menstrual hygiene. Banega Swasth India will also be taking forward the dream of Swasth Bharat, the campaign feels that only a Swachh or clean India where toilets are used and open defecation free (ODF) status achieved as part of the Swachh Bharat Abhiyan launched by Prime Minister Narendra Modi in 2014, can eradicate diseases like diahorrea and the country can become a Swasth or healthy India.

Highlights: Banega Swasth India Season 9 Finale

Folk Music For A Swasth India

Folk Music

Reckitt’s Commitment To A Better Future

India’s Unsung Heroes

Women’s Health

हिंदी में पढ़ें